Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001171843-26-004451

Chief Executive Officer acquired 3,378 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nijhawan Pardeep · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-02 Grant or award : show line 1 in the form +3,378 888,062 D
Loading xslF345X06/ownership.xml…